To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

NCT00050648 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Daclizumab
DRUG: Cyclosporine
DRUG: cyclosporine and Daclizumab

Sponsor

Rockefeller University

Collaborators

[object Object]